Honz Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Kangzhi Pharmaceutical Co., Ltd. is a listed enterprise focused on children's health (stock abbreviation: Kangzhi Pharmaceutical, stock code: 300086). Our main business covers fields such as children's medicine, maternal and child health products, and medical services. We are a national high-tech enterprise and have taken the lead in establishing a postdoctoral research workstation with children's medicine as our main research direction. The company adheres to the corporate tenet of "sincerity, benevolence, and medicine, benefiting humanity", actively implements the "Children's Health Strategy" and "boutique strategy", and ingeniously creates a national brand for the children's health industry. Kangzhi Pharmaceutical has been deeply involved in the children's medication market for many years, forming a complete product line. It is one of the few pharmaceutical enterprises in China that has a complete industry chain of children's medication research and development, production, and sales. The company has a nationwide layout and five major production bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong provinces and cities, with highly automated and intelligent production lines. The company has advanced research and development equipment and an excellent research and development team. In 2018, Kangzhi Pharmaceutical acquired Zhongshan Aihu Daily Necessities Co., Ltd., expanding its business layout to the maternal and child health sector, and the Kangzhi Children's Health landscape is becoming increasingly perfect. Love Care Company has established cooperation with multiple research institutions and universities both domestically and internationally, and has been invited to participate in the development of the "Liquid Detergent for Infant and Child Clothing" standard. It is a leading enterprise in the field of maternal and infant health in China. At the beginning of 2020, the COVID-19 swept the world. Kangzhi Pharmaceutical was ordered to produce emergency masks and other protective materials. It took only 8 days to build the first disposable medical mask production line in Hainan, and successfully obtained the ENISO13485:2016 EU quality management system certification. In September 2020, it became a manufacturer of anti epidemic masks of the United Nations Development Programme. Kangzhi Pharmaceutical is committed to becoming a leader in China's children's health industry, continuously deepening and developing in the field of children's health. It has won honors such as "Top 10 Most Growing Pharmaceutical Enterprises in China", "Forbes China Potential Enterprise", "Top 500 Asian Brands", "Top 100 Enterprises in China's Medical and Pharmaceutical Industry", and "Specialized, Refined, and New Enterprises in Hainan Province". In the future, Kangzhi will rely on the historical opportunity of upgrading the construction of Hainan Free Trade Port into a national strategy, steadfastly develop the children's health industry, uphold the corporate spirit of "sincerity, care, and innovation", take "making children use good medicine" as its own responsibility, adhere to the development strategy of "specialization, precision, and novelty", focus on safe and effective research and development of children's drugs, be a pioneer in the application of advanced technology in the field of children's health products and services, and do a healthy life for children Promoters and guardians of healthy growth. |
| Headquarter | Haikou |
| Establish Date | 1/20/1994 |
| Listed Code | 300086.SZ |
| Listed Date | 5/26/2010 |
| Chairman | Hongjiang Tour. |
| CEO | Hong Jiangtao. |
| Website | www.honz.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
